Sanofi SA (FRA:SNW)
€ 92.33 -1.89 (-2.01%) Market Cap: 115.85 Bil Enterprise Value: 125.29 Bil PE Ratio: 21.94 PB Ratio: 1.59 GF Score: 81/100

Sanofi SA at Cowen Healthcare Conference (Virtual) Transcript

Mar 02, 2021 / 06:30PM GMT
Release Date Price: €75.86 (-0.03%)
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good afternoon, and welcome back. We're very pleased to have with us, once again this year, Sanofi. Representing the company is Bill Sibold, who's Executive Vice President and Head of Sanofi Genzyme; and Frank Nestle, who is Head of Research and Chief Scientific Officer.

There are many, many positive developments underway at Sanofi, and we're eager to dive into each and learn more about all of them.

Questions & Answers

Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

So without further ado, let me start out with the obligatory, big picture question I guess I'll put it to Bill. When you in peer in your crystal ball over the next 4 years, what do you think could emerge from the Biden administration relative to pricing? And what impact would it have on Sanofi?

William J. Sibold
Sanofi - EVP of Sanofi Genzyme

Well, first of all, Steve, thanks for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot